# OnCo record nct06358430 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06358430/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06358430", "NCT06358430" ;
  schema:name "Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)"@en ;
  schema:description "An early trial studying the safety and activity of experimental treatment. Its registry status does not establish patient benefit."@en ;
  schema:url <https://onco.cc/trials/nct06358430/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06358430> ;
  onco:status "active" ;
  onco:phase "1" ;
  schema:startDate "2024-12-02" ;
  onco:targets <https://onco.cc/targets/trop2/> ;
  onco:drugs <https://onco.cc/drugs/trop2-car-il15-cord-blood-nk/>, <https://onco.cc/drugs/cetuximab/> .